What was studied?
The researchers used INS-1E and alpha-TC1 cell lines as models of pancreatic beta and alpha cells. Experiments assessed insulin, glucagon, MOTS-c secretion, cell viability and apoptosis under different metabolic conditions.
What did the researchers report?
MOTS-c lowered insulin-related secretion and expression in the beta-cell model and increased glucagon-related measurements in the alpha-cell model. Insulin, glucagon, glucose and fatty acids also affected MOTS-c secretion in the experimental system.
What are the limits?
Cell-line secretion patterns cannot predict net glucose control in a whole organism. The differing responses are not evidence that a material will improve diabetes outcomes. These mechanistic experiments should be kept separate from human intervention trials and clinical safety claims.
Original editorial summary by Sulan Peptide. Based on the source abstract; consult the full paper for methods, analyses, funding and disclosures.